尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Reinhart Charles A. III, 首席财务官. Insider active across 1 company, notably Pacira BioSciences, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €323k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Charles A. Reinhart III is the Chief Financial Officer of Pacira BioSciences, Inc. In this role, he oversees the company's financial management, including financial planning and performance analysis. His expertise is essential in supporting Pacira's growth strategy and ensuring financial transparency.